Immunization of rabbits against a bacterial pathogen with an alginate microparticle vaccine

Journal of Controlled Release

Volumn 85, Issue 1-3, 2002, Pages 227-235

  Suckow, Mark A ^a   Jarvinen, Lamis Z ^b   HogenEsch, Harm ^c   Park, Kinam ^d   Bowersock, Terry L ^e  

^a UNIVERSITY OF NOTRE DAME   (United States)

^b DARTMOUTH COLLEGE   (United States)

^c PURDUE UNIVERSITY   (United States)

^d PURDUE UNIVERSITY   (United States)

^e PFIZER INC   (United States)

Author keywords

Alginate; Microparticles; Pasteurella multocida; Rabbit

Indexed keywords

ALGINIC ACID; CHOLERA TOXIN; IMMUNOGLOBULIN G; THIOCYANATE; VACCINE; BACTERIAL VACCINE; GLUCURONIC ACID; HEXURONIC ACID; IMMUNOGLOBULIN A; MICROSPHERE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; DRUG MECHANISM; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION PREVENTION; NASOPHARYNX; NONHUMAN; PARTICULATE MATTER; PASTEURELLA MULTOCIDA; PRIORITY JOURNAL; PROVOCATION TEST; RABBIT; ANIMAL; BLOOD; DRUG DELIVERY SYSTEM; GRAM NEGATIVE INFECTION; IMMUNOLOGY; MALE; METHODOLOGY;

ALGINATES; ANIMALS; BACTERIAL VACCINES; DRUG DELIVERY SYSTEMS; GLUCURONIC ACID; HEXURONIC ACIDS; IMMUNIZATION; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MICROSPHERES; PASTEURELLA INFECTIONS; PASTEURELLA MULTOCIDA; RABBITS;

EID: 0037073644     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(02)00277-8     Document Type: Article

References (31)

1. DeLong D., Manning P.J. Bacterial diseases. Manning P.J., Rinlger D.H., Newcomer C.E. The Biology of The Laboratory Rabbit. 1994;131-170 Academic Press, Orlando.
2. Broome R.L., Brooks D.L. Efficacy of enrofloxacin in the treatment of respiratory Pasteurellosis in rabbits. Lab. Anim. Sci. 41:1991;572-576.
3. Suckow M.A., Martin B.J., Bowersock T.L., Douglas F.A. Derivation of Pasteurella multocida-free rabbit litters by enrofloxacin treatment. Vet. Microbiol. 51:1996;161-168.
4. Manning P.J. Naturally occurring Pasteurellosis in laboratory rabbits: chemical and serological studies of whole cells and lipopolysaccharides of Pasteurella multocida. Infect. Immun. 44:1984;502-507.
5. Lu Y.S., Afendis S.J., Pakes S.P. Identification of immunogenic outer membrane proteins of Pasteurella multocida A:3 in rabbits. Infect. Immun. 56:1988;1532-1537.
6. Ringler D.H., Peter G.K., Chrisp C.E. Protection of rabbits against experimental Pasteurellosis by vaccination with a potassium thiocyanate extract of Pasteurella multocida. Infect. Immun. 49:1985;498-504.
7. Suckow M.A., Bowersock T.L., Nielsen K., Grigdesby C.F. Enhancement of respiratory immunity to Pasteurella multocida by cholera toxin in rabbits. Lab. Anim. 30:1996;120-126.
8. O'Hagan D.T., Rahman D., McGee J.P., Jeffery H., Davies M.C., Williams P., Davis S.S., Challacombe S.J. Biodegradable microparticles as controlled release antigen delivery systems. Immunology. 73:1991;239-242.
9. Eldridge J.H., Staas J.K., Tice T.R., Gilley R.M. Biodegradable poly(DL-lactide-co-glycolide) microspheres. Res. Immunol. 143:1992;557-563.
10. Lim F., Sun A.M. Microencapsulated islets as bioartificial endocrine pancreas. Science. 210:1980;908-910.
11. Tatarkiewicz K., Hollister-Lock J., Quickel R.R., Colton C.K., Bonner-Weir S., Weir G.C. Reversal of hyperglycemia in mice after subcutaneous transplantation of macroencapsulated islets. Transplantation. 67:1999;665-671.
12. Lam P.K., Chan E.S. In vitro elution of antibiotic from antibiotic-impregnated calcium alginate wound dressing. J. Trauma. 48:2000;361-362.
13. Kawai K., Suzuki S., Tabata Y., Ikada Y., Nishimura Y. Accelerated tissue regeneration through incorporation of basic growth factor-impregnated gelatin microspheres into artificial dermis. Biomaterials. 21:2000;489-499.
14. Aggarwal N., HogenEsch H., Guo P., North A., Suckow M., Mittal S.K. Biodegradable alginate microspheres as a delivery system for naked DNA. Can. J. Vet. Res. 63:1999;148-152.
15. Suzuki Y., Tanihara M., Nishimura Y., Suzuki K., Yamawaki Y., Kudo H., Kakimaru Y., Shimizu Y. In vivo evaluation of a novel alginate dressing. J. Biomed. Mater. Res. 48:1999;522-527.
16. Kataoka K., Suzuki Y., Kitada M., Ohnishi K., Suzuki K., Tanihara M., Ide C., Endo K., Nishimura Y. Alginate, a bioresorbable material derived from brown seaweed, enhances elongation of amputated axons of spinal cord in infant rats. J. Biomed. Mater. Res. 54:2001;373-384.
17. Kwok K.K., Groves M.J., Burgess D.J. Production of 5-15 microns diameter alginate-polylysine microcapsules by an air-atomization technique. Pharm. Res. 8:1991;341-344.
18. Glorioso J.C., Jones G.W., Rush H.G., Pentler L.J., DaRif C.A., Coward J.E. Adhesion of type A Pasteurella multocida to rabbit pharyngeal cells and its possible role in rabbit respiratory tract infections. Infect. Immun. 35:1982;1103-1109.
19. Kiyono H., Kweon M.N., Hiroi T., Takahashi I. The mucosal immune system: from specialized immune defense to inflammation and allergy. Acta Odontol. Scand. 59:2001;145-153.
20. O'Hagan D.T., McGee J.P., Holmgren J., Mowat A.M., Donachie A.M., Mills K.H., Gaisford W., Rahman D., Challacombe S.J. Biodegradable microparticles for oral immunization. Vaccine. 11:1993;149-154.
21. Eldridge J.H., Staas J.K., Meulbroek J.A., McGhee J.R., Tice T.R., Gilley R.M. Biodegradable microspheres as a vaccine delivery system. Mol. Immunol. 28:1991;287-294.
22. McQueen C.E., Boedeker E.C., Reid R., Jarboe D., Wolf M., Le M., Brown W.R. Pili in microspheres protect rabbits from diarrhea induced by E. coli strain RDEC-1. Vaccine. 11:1993;201-206.
23. Singh M., Li X.M., Wang H., McGee J.P., Zamb T., Koff W., Wang C.Y., O'Hagan D.T. Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal models. Vaccine. 16:1998;346-352.
24. Bessen D., Fischetti V.A. Influence of immunization with synthetic peptides corresponding to conserved epitopes of M protein on mucosal colonization by group A Streptococci. Infect. Immun. 56:1988;2666-2672.
25. Bourgin I., Chardes T., Mevelec M.N. Amplification of the secretory IgA response to Toxoplasma gondii using cholera toxin. FEMS Microbiol. Lett. 81:1991;265-272.
26. Czinn S.J., Nedrud J.G. Oral immunization against Helicobacter pylori. Infect. Immun. 59:1991;2359-2362.
27. Russell M.W., Wu H.Y. Distribution, persistence, and recall of serum and salivary antibody responses to peroral immunization with protein antigen I/II of Streptococcus mutans coupled to the cholera toxin B subunit. Infect. Immun. 59:1991;4061-4070.
28. Takahashi I., Okahashi N., Kanamoto T., Asakawa H., Koga T. Intranasal immunization of mice with recombinant protein antigen of serotype C Streptococcus mutans and cholera toxin B subunit. Arch. Oral Biol. 35:1990;475-477.
29. Kikuta K., Hirabayashi Y., Magamine T. Cross-protection against influenza B type virus infection by intranasal inoculation of the HA vaccine combined with cholera toxin B subunit. Vaccine. 8:1990;595-599.
30. Liange X., Lamm M.E., Nedrud J.G. Oral administration of cholera toxin-Sendai virus conjugate potentiates gut and respiratory immunity against Sendai virus. J. Immunol. 141:1988;1495-1501.
31. Suckow M.A., Bowersock T.L., Nielsen K., Chrisp C.E., Frandsen P.L., Janovitz E.B. Protective immunity to Pasteurella multocida heat-labile toxin by intranasal immunization in rabbits. Lab. Anim. Sci. 45:1995;526-532.